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Introduction 
Osteoarthritis of the knee causes pain 
and disability. Degeneration of the 
cartilage was traditionally considered to 
be the primary change associated with 
OA, but in recent years evidence has 
emerged to suggest that it is a disease 
of the entire joint, involving interactions 
between different tissues (Javaid and 
Arden, 2013).
Treatments to prevent, slow down 
or halt OA progression may help to 
prevent the associated pain and loss of 
function frequently reported by patients, 
and avoid invasive joint replacement 
surgery in the future. A recent study 
demonstrated that the drug Strontium 
Ranelate slowed down the progression 
of radiographic joint space narrowing 
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associated with knee OA, as well as 
reducing pain in patients with knee oste-
oarthritis compared to those without the 
disease (Reginster et al 2013). Knee OA 
progresses at different rates in different 
people, so in some patients it never 
becomes severe and thus never requires 
joint replacement surgery. If preventative 
treatments are to be targeted to those 
that need it most, the use of diagnostic 
imaging is likely to be integral. 
Radiographs are currently the most 
commonly used radiological imaging 
technique for the diagnosis and 
monitoring of knee OA, by identifying 
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Abstract
Osteoarthritis (OA) causes pain and reduced mobility. The primary outcome measure of radiography for knee OA is joint space 
narrowing (JSN), which occurs late in disease progression, often alongside increased patient reported symptoms, making ra-
diography unsuitable for early diagnosis. Dual-energy X-ray absorptiometry (DXA), a measure of areal bone mineral density 
(aBMD), has the potential to be used as an earlier marker of OA-associated bone changes than radiographic imaging, thereby 
potentially also preceding increases in patient reported symptoms. Changes in aBMD may occur before JSN in patients with 
knee OA, but the accuracy with which aBMD represents OA pathogenesis is currently unclear. Measures of aBMD theoretically 
increase in proportion with bone depth, regardless of density, which means that osteoarthritis-associated changes in tibial 
bone depth may falsely elevate aBMD. This study aims to create an accurate estimate of volumetric bone mineral density 
(vBMD), and to explore the relationship between bone mineral density (BMD) and anthropometric measures. A population 
of 30 retrospectively, consecutively selected patients with Kellgren-Lawrence grade II-IV knee OA will be established from an 
existing research cohort. Previously collected knee DXA images will be co-registered with knee magnetic resonance imaging 
(MRI). Tibial bone depth will be calculated from MRI and each participantcipaBMD score will then be adjusted accordingly. 
The relationship between adjusted (vBMD) and unadjusted (aBMD) scores will be explored. Measuring bone changes early in 
the development of knee OA using DXA could be a relatively cheap, non-invasive and fast method for targeting preventative 
treatment, thus potentially minimising the pain and loss of mobility associated with progressive knee OA
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changes such as joint space narrowing 
(JSN), a radiographic manifestation of 
cartilage loss. These changes though, 
occur relatively late on during the 
disease, making radiography unsuitable 
for early disease detection (Bruyere et 
al, 2003). In addition, one study found 
that 15-81% of participants with radio-
graphic knee OA experienced knee pain, 
and 15-76% of those with knee pain has 
radiographic evidence of knee OA. This 
suggests that knee pain is an imprecise 
marker of radiographic knee OA, and that 
radiography is inadequate for predicting 
the onset of OA-associated knee pain or 
disability (Bedson and Croft, 2008).
On the other hand, abnormalities 
detected by Magnetic Resonance Imaging 
(MRI) explain knee pain in osteoarthritis 
(Yusuf et al, 2011), making MRI a useful 
clinical utility in patients that present with 
clinical knee OA, but whose radiographs 
demonstrate no evidence of the disease. 
Bone marrow lesions have also been 
shown to predict disease progression 
(Driban et al, 2013), and changes in 
their volume are detectable by MRI 
within 6-12 weeks (Felson et al, 2012), 
whereas changes in cartilage structure 
are not detectable over a 6 month 
period (Hunter et al, 2010). This evidence 
supports the monitoring of bone marrow 
lesions to identify short-term structural 
changes in response to therapeutic 
intervention. On the other hand, MRI is 
currently expensive and time-consuming, 
which limits its universal application 
to a disease which is likely to grow in 
prevalence globally, as a consequence 
of an ageing population and obesity 
epidemic (Cross et al, 2013). Quantita-
tive computed tomography (pQCT) is 
sensitive to certain disease changes, but 
is also expensive, not routinely available 
in clinical practice, and emits a high 
dose of ionising radiation, which can be 
harmful to patients.
Dual-energy X-Ray Absorptiometry 
(DXA) scanning estimates the strength 
of a selected area of bone by measuring 
its areal density, and therefore may be 
able to measure OA-associated changes 
in bone structure that occur prior to 
JSN. It benefits from being relatively 
fast, cheap, readily available in clinical 
practice and emits a significantly lower 
dose of ionising radiation than pQCT 
and radiography. On the other hand, 
the bone around the joint of an osteo-
arthritic knee expands. As DXA is only a 
two-dimensional (2D) measurement, it 
does not account for bone depth. Any 
significant increase in such may falsely 
elevate measurement, thus leading to an 
overestimation of bone strength in knee 
OA patients. The main aim of this study is 
therefore to determine the potential rela-
tionship between bone depth adjusted 
and standard BMD in patients with knee 
OA. A series of objectives are therefore 
as follows: to create an accurate estimate 
of vBMD, to explore the relationship 
between aBMD and vBMD, and to 
determine whether aBMD and vBMD are 
correlated with anthropometric meas-
urements.
Literature Review
Osteoarthritis is a common, degenerative 
joint disease associated with pain and 
loss of function (Bijlsma et al, 2011). The 
societal and financial implications are also 
noteworthy (Litwic et al, 2013), whilst 
incidence is rising in line with an ageing 
population and the epidemic of obesity 
(Bijlsma et al, 2011). The eventual clinical 
outcome for many patients with knee 
and hip OA is total joint replacement 
(Dieppe et al, 1999). Although joint 
replacement manages symptoms and 
returns function for the majority, it is an 
invasive and expensive procedure that 
is only effective for a limited amount of 
time (Pelletier et al, 2013). This highlights 
the importance of effective diagnosis 
and treatment, with early identification 
being critical to clinical decision making 
and targeting of therapeutic interven-
tion. This is particularly pertinent in light 
of the positive effects demonstrated by 
the drug Strontium Ranelate in a recent 
double-blind, randomised placebo-con-
trolled trial (Reginster et al, 2013). In 
comparison to controls, participants 
given the drug experienced significantly 
less JSN. Those given 2g/day experienced 
greater reductions in pain sub-scores and 
negative health outcomes associated with 
OA, than those given 1g/day. This study 
illustrates that future knee OA treatment 
may be focused on prevention rather 
than surgical intervention, and highlights 
the importance for developing diagnostic 
imaging techniques to facilitate such.
In the majority of cases diagnostic 
assessment of OA involves the 
combination of clinical history, physical 
examination and radiographic imaging 
(Braun and Gold, 2012). For inves-
tigation of knee OA, imaging most 
commonly comprises radiographs in 
two planes: weight bearing antero-pos-
terior (AP) and lateral (Chaisson et al, 
2000). During the progression of OA, 
multiple boney changes may occur, 
including: osteophyte development, 
subchondral sclerosis, subchondral cysts 
and JSN (Braun and Gold, 2012). Several 
semi-quantitative methods have been 
developed for grading the severity of OA 
from a radiograph (Marshall et al, 2008; 
Hellio Le Graverand et al, 2009; Trivedi 
et al, 2010). The Kellgren-Lawrence (KL) 
grading system (Kellgren and Lawrence, 
1957) is validated (Kijowski et al, 2006) 
and commonly used in clinical practice 
to determine the severity of OA at the 
tibio-femoral joint (Emrani et al, 2008).
Joint space narrowing is the most 
commonly used measure of disease 
progression detected by radiography 
(Emrani et al, 2008). In the cycle of knee 
OA, though, cartilage thickness initially 
increases, before decreasing as the 
disease progresses (Bet al, 2 et al, 1995). 
This makes radiography detected JSN 
unsuitable for early disease diagnosis. In 
addition, Kijowski et al (2006) reported 
sensitivity of JSN for the detection of 
cartilage degeneration in the medial 
tibio-femoral compartment as 67% (95% 
CI: 58-75), whilst sensitivity of other 
radiography detected bone changes 
ranged from 10-46%, and figures at 
the lateral compartment were lower 
for all measures. The study was open 
to selection bias as all participants in 
the study group were symptomatic and 
selected from a database of MRI knee 
examinations performed at the centre 
in the preceding years. Even so, use of 
cartilage degeneration by arthroscopy 
seems an appropriate reference gold 
standard, and the design was suitable 
for a diagnostic test study. The sensitivity 
of radiographic features to the presence 
of knee OA pathophysiology were 
sub-optimal, thus presenting a major 
limitation of radiography, and indicating 
room for advancement in the radiological 
diagnosis of knee OA.
Traditionally, breakdown of joint 
cartilage was thought to be the primary 
change associated with OA. In recent 
years, though, evidence has emerged 
suggesting that OA is a disease involving 
the entire joint (Javaid and Arden, 2013). 
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In 1986, Radin and Rose suggested that 
bone, in addition to cartilage, absorbs 
shock placed on joints by impact loading, 
and that high cortical bone mass may 
favour OA development, given the 
associated increased mechanical stress 
on cartilage. Indeed, in 1993 Dieppe et al 
used bone scintigraphy to demonstrate 
that bone changes occur very early on 
in the progression of OA, the first unde-
tectable by radiography. Using a cohort 
study design over a five-year period, 
the authors were able to prospectively 
determine early risk factors for knee OA 
progression. Although internal validity 
is slightly limited by what is a relatively 
short follow-up period in the cycle of OA 
progression, the study is otherwise robust 
in design. The findings were reinforced 
by Buckland-Wright et al (1996), who 
found that changes in bone structure 
were strongly correlated with the degree 
of joint space loss in 90 osteoarthritic 
knees, and that the earliest change to 
subchondral bone was an increase in the 
thickness of horizontal trabeculae. This 
suggests that cortical bone nearest to the 
joint, and trabecular bone directly distal 
to it, increase in density during knee 
OA, warranting investigation of imaging 
techniques that could measure these 
changes.
Distal to these areas of increased density, 
evidence suggests that trabecular bone 
decreases in strength. Karvonen et al 
(1998) used DXA to measure periar-
ticular regions of the knee in both poste-
ro-anterior (PA) and lateral projections, 
producing three-dimensional (3D) 
estimates of bone strength. Comparing 
a group of 62 patients with mild knee 
OA to a group of 62 without knee OA, 
they reported statistically significant 
decreases in aBMD in all subchondral 
regions. In addition, they compared bone 
mineral density (BMD) measured in one 
projection (2D), to BMD measured in 
two projections (3D). They found that 
the average BMD of the study group 
compared to the controls was 7.3% lower 
by 2D measurement, and 13.3% lower 
by 3D measurement. The OA group only 
had mild OA, limiting external validity 
to this group. Nevertheless, findings 
suggest that not only does BMD decrease 
in some regions of periarticular bone 
of the tibia with mild OA independent 
of osteoporosis at other sites, but also 
that 2D measurement is confounded by 
bone depth in this group. As tibial bone 
size appears to be positively correlated 
with OA progression (Ding et al, 2007), 
this effect could be more profound in the 
later stages of knee OA, meaning that 
bone changes measured by DXA could be 
inaccurate at present.
DXA is a bone densitometry scanning 
technique, whereby the density of 
a given area of bone is estimated 
(Bonnick, 2010), based on the amount 
of x-radiation absorbed in that region. 
With the ability to quantify bone density 
in almost every region of the body, 
DXA has many potential roles in clinical 
practice (Bonnick, 2010). When applied 
to patients with knee osteoarthritis, it 
has proven to predict radiographic joint 
space narrowing of the knee, indicating 
a potential role in monitoring early stage 
OA (Bruyere et al, 2003). DXA also offers 
many advantages over other densi-
tometry techniques, such as peripheral 
quantitative computed tomography, in 
that it is faster, emits a lower amount of 
radiation, has a higher level of precision 
and is readily available in clinical practice 
(El Maghraoui et al, 2006).
Despite the benefits of DXA, though, 
it is limited by being a 2D imaging 
technique. It measures density within a 
given area of bone (width multiplied by 
height), thus the depth of a bone is not 
accounted for. Bone depth subsequently 
seems to influence aBMD measurement 
in populations where bone size changes, 
such as paediatrics (Cvijetit and Kord 
t, 2004). Some studies using DXA have 
reported that aBMD of the tibia increased 
in patients with knee OA (Bruyere et al, 
2003; Clarke et al, 2004), whereas a study 
using the 3D technique pQCT found that 
volumetric bone size, not volumetric 
bone mineral density (vBMD), increased 
with knee OA (Abdin-Mohamed et al, 
2009). It is possible, therefore, that the 
observed increase in aBMD amongst 
patients with knee OA in these studies is 
artifactual, caused by an increase in bone 
depth that is associated with OA (Ding 
et al, 2007), as opposed to an increase 
in density. One might initially consider 
this clinically relevant, because if aBMD 
is significantly higher in the bone of an 
OA-affected joint, then it could be used 
to differentiate patients with knee OA 
from those without. In reality, this is 
extremely undesirable. An increase in 
BMD measurement suggests a decrease 
in fracture risk (Unnanuntana et al, 
2010), whereas evidence suggests that 
the opposite is true for OA patients- that 
they are at increased risk of fracture 
(Arden et al, 1996; Arden et al, 1999; 
Bergink et al, 2003). The relationship 
between OA, osteoporosis and fracture 
risk is complex (Javaid and Arden 2013). 
If DXA is to be utilised to facilitate early 
diagnosis of knee OA, it may also have an 
application for monitoring fracture risk 
in this population. If DXA is to be used to 
target therapeutic intervention to those 
at highest risk of OA and/or fracture, 
then a high degree of accuracy is vital.
Carter et al (1992) proposed an early 
method of accounting for bone size 
using DXA. Areal bone mineral density 
is calculated by dividing bone mineral 
content by the projected area of the bone 
being measured. The authors recognised 
that any region of bone being measured 
has an average depth, and that to know 
this factor would allow calculation of 
volumetric bone mineral density, and thus 
removal of any confounding influence of 
bone depth. It was therefore estimated 
by inputting factors that were expected to 
scale proportionally to it. Three methods 
were tested for calculating bone depth, 
each with a different assumption. The 
first was that bone width, length and 
depth are all proportional, or in other 
words, the bone is cuboid in shape. The 
second method assumed that the whole 
skeleton is geometrically similar, and that 
bone depth is proportional to height. The 
third method assumed that the average 
width of the bone is proportional to the 
average depth of the bone. Although 
these approaches seem to remove a 
dependence of aBMD on a patientientt 
bone width, length and depth are all 
proportional, or in other words, the bone 
is cuboid in shape. The second method 
assumed that the whole skeleton is 
geometrically similar, and that bone 
depth  have not yet been applied to knee 
DXA scans in a population with knee oste-
oarthritis.
Another approach is to combine PA and 
lateral DXA scans of the region of interest 
(Duboeuf et al. 1994). Postero-anterior 
aBMD correlates significantly with height 
and weight at the 1% level, and body 
mass index at the 5% level (Jergas et al. 
1995). By accounting for bone depth 
using the lateral scans, no significant 
correlation was found with any of these 
factors. This further suggests that PA 
aBMD is dependent on bone size. The 
extra time, cost and ionising radiation 
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exposure associated with performing an 
additional, lateral, projection limit the 
value of the potential application of this 
approach in clinical practice.
Two-dimensional medical imaging 
techniques, such as DXA, are able to 
measure the area of a bone: width 
multiplied (X) by height. Three-dimen-
sional techniques, such as MRI, have 
the ability to measure the volume of a 
bone: width X height X depth. Whilst 
DXA benefits from being able to measure 
bone mineral density, it is limited by only 
being able to measure this within a given 
area of bone rather than within a volume. 
MRI is unable to measure bone mineral 
density, but it is capable of measuring 
bone volume. Combining a measure 
of volume from MRI, with a measure 
of density from DXA, offers a novel 
approach to estimating the volumetric 
density of bone, which is potentially more 
accurate than other estimates. To the 
author’s knowledge there are currently 
no published approaches that co-register 
DXA images with a 3-dimensional imaging 
technique, such as MRI, to estimate 
vBMD. This study therefore aims to 
create an accurate estimate of vBMD, to 
explore the relationship between aBMD 
and vBMD, and determine whether 
aBMD and vBMD are correlated with 
anthropometric measurements.
Research Question
Are bone mineral density measurements 
of the osteoarthritic knee falsely elevated 
by anthropometric factors?
Null Hypotheses
1. Areal and volumetric bone 
mineral density measures of the osteoar-
thritic knee are uncorrelated
2. Areal bone mineral density is 
uncorrelated with height, weight and 
tibial length
3. Volumetric bone mineral density 
is uncorrelated with height, weight and 
tibial length
Proposed Design
This proposal uses existing data gathered 
as part of an ongoing epidemiological 
cohort study; the VIDEO trial. The VItamin 
D Evaluation in Osteoarthritis (VIDEO) 
trial is a randomised, double-blind, 
placebo controlled study of Vitamin D 
supplementation in the management of 
symptomatic knee OA. The study was 
conducted began in 2005 as a collabo-
ration between the Medical Research 
Council Clinical Trials Unit (MRC CTU), 
Royal National Orthopaedic Hospital, 
Royal Free and University College London.
A retrospective cross-sectional design 
Table 1: Inclusion and Exclusion Criteria
Inclusion Criteria Exclusion Criteria
KL-grade II-IV radiographic OA of the 
knee
Knee DXA scan incomplete/insufficient 
information
Had DXA and MRI of their OA-affected 
knee
Knee MRI scan incomplete/insufficient 
information
DXA and MRI scans performed within 
one month of each other
Knee DXA or MRI data unavailable
using a repeated measures analysis 
will be utilised to observe MRI and DXA 
images. To date, few studies of this 
nature have been reported, and as such 
sample size estimation was prohibited. A 
sample size of 50 patients was therefore 
pragmatically selected.
The target population is patients with 
osteoarthritis of the knee and a KL 
grade 2-3. DXA and MRI scans of their 
OA-affected knee must have been 
performed within 1  month of each 
other, to limit changes in bone structure 
between scans. Inclusion and exclusion 
criteria for this project are detailed in 
table 1.
Data Analysis
The first step of data analysis will be to 
identify two regions of interest (ROI 2-3. 
DXA and MRI scansaBMD and vBMD. 
Femoral and tibial cartilage degeneration 
occurs at a similar rate and stage in the 
presence of knee OA, but measuring the 
bone of the distal femur with 2D imag-
ing techniques like DXA is limited by the 
superimposition of the patella, the posi-
tion of which is highly dependent on the 
position of the patients knee during the 
scan (Cicuttini et al, 2001). Consist with 
previous studies, and to maximise re-
producibility, only the proximal tibia will 
be analysed during this study. Current 
evidence suggests that aBMD of cortical 
bone at the proximal tibia increases in 
the presence of knee OA (Clarke et al, 
2004), whereas aBMD of the trabecular 
bone distal to it may decrease in density 
(Karvonen et al, 1998). Other osteoarthri-
tis-associated changes that affect aBMD, 
such as osteophytes, are most common 
nearest the joint - where cortical bone 
is abundant (Nagaosa et al, 2002). To 
minimise confounding variables, regions 
that incorporate solely trabecular bone 
have been selected. Structural changes 
to bone associated with knee OA differ 
between the medial and lateral compart-
ments (Lo et al, 2006), so two regions will 
be created: one medial and one lateral. 
Hologic DXA software will be used to ap-
ply the ROIthe ROIolely trabecular bone 
have been selected. Structural changes 
to bone associate
The image files for the analysed knee DXA 
scans, the whole-body DXA scans and 
knee MRI scans will be exported. Soft-
ware will then be created to co-register 
DXA and MRI data, a process that is sum-
marised in figure 1. The average depth 
of the tibia at the previously determined 
regions of interest on the DXA image will 
then be calculated. This process will be 
repeated for intra-rater agreement anal-
ysis. Volumetric BMD will be calculated 
by dividing BMC by the average depth of 
the tibia.
Statistical Analysis
All analysis will be conducted using IBM 
SPSS (version 21). The distribution of 
aBMD and vBMD scores will be analysed 
by observing a histogram. Assuming nor-
mality, two tests of intra-rater agreement 
will be performed using a two-way mixed 
intra-class correlation model: one of ap-
plying the ROI’s to the knee DXA image, 
one of calculating average tibial depth. 
A Pearson correlation test, or Spear-
manearmansts of intra-rater agreement 
will be performed using a two-way mixed 
intra-class correlatationship between 
aBMD and vBMD. The same test will then 
be used to determine whether aBMD and 
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